• Users Online: 206
  • Print this page
  • Email this page
BRIEF REPORT
Year : 2016  |  Volume : 5  |  Issue : 1  |  Page : 12

Galectin-3 serum levels are independently associated with microalbuminuria in chronic heart failure outpatients


1 Department of Cardiothoracic, Cardiology Unit, Policlinic University Hospital, Bari, Italy
2 DEA Department, Cardiology Unit, San Filippo Neri Hospital, Rome, Italy
3 Department of Emergency and Organ Transplantation, School of Cardiology, University of Bari, Bari, Italy
4 Cardiology Unit, Hospital Department, Chioggia ULSS 14, Chioggia, Italy
5 Cardiology Unit, Cardiology Department, San Paolo Hospital, Bari, Italy
6 Department of Diagnostic Pathology, Bioimages and Public Health, Policlinic University Hospital, Bari, Italy
7 Clinical Pathology Unit, University of Bari, Bari, Italy

Correspondence Address:
Massimo Iacoviello
Department of Cardiothoracic, Cardiology Unit, Policlinic University Hospital, Bari
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.5812/cardiovascmed.28952

Get Permissions

Background: Galectin-3 (Gal-3) is a novel biomarker reflecting inflammation status and fibrosis involving worsening of both cardiac and renal functions. Objectives: The aim of this study was to evaluate the relationship between Gal-3 serum levels and microalbuminuria in a group of chronic heart failure (CHF) outpatients. Patients and Methods: We enrolled CHF outpatients having stable clinical conditions and receiving conventional therapy. All patients underwent clinical evaluation, routine chemistry analysis, echocardiography, and evaluation of the urinary albumin/creatinine ratio (UACR). Results: Among the patients enrolled, 61 had microalbuminuria (UACR, 30-299) and 133 normoalbuminuria (UACR, < 30). Patients with normoalbuminuria showed significantly higher levels of Gal-3 than those without (19.9 ± 8.8 vs. 14.6 ± 5.5 ng/mL). The stepwise regression analysis indicated that Gal-3 was the first determinant of microalbuminuria (odds ratio [OR]: 1.08; 95% confidence interval [CI]: 1.02 - 1.14, P = 0.012), followed by diabetes (OR 2.14; 95% CI: 1.00 - 4.57; P = 0.049) and high central venous pressure (OR 2.80; 95% CI: 1.04 - 7.58; P= 0.042). Conclusions: Our findings indicate an independent association between Gal-3 levels and microalbuminuria, an early marker of altered renal function. This suggests the possible role of Gal-3 in the progression of cardiorenal syndrome in CHF outpatients.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed676    
    Printed39    
    Emailed0    
    PDF Downloaded128    
    Comments [Add]    
    Cited by others 6    

Recommend this journal